Temocillin

![Temocillin synthesis:[7]](/uploads/202502/15/Temocillin_synthesis2612.png)
Temocillin is a β-lactamase-resistant penicillin introduced by Beecham, marketed by Eumedica Pharmaceuticals as Negaban. It is used primarily for the treatment of multiple drug-resistant, Gram-negative bacteria. It is a carboxypenicillin.